title: Course and outcome of dialysis pericarditis in diabetic patients treated with maintenance hemodialysis.
abstract: BACKGROUND
  This observational study investigated the course and outcome of dialysis pericarditis in diabetic dialysis patients, as previous reports found that in contrast to uremic pericarditis, which responds in most cases to intensive hemodialysis, dialysis pericarditis resolves with intensification of hemodialysis in fewer cases.
  
  
  METHODS
  From 2002 through 2006, 88 maintenance hemodialysis patients (47 diabetic and 41 non-diabetic) were referred for management of dialysis pericarditis.
  
  
  RESULTS
  Dialysis pericarditis in 85.1% of diabetic and 82.9% of non-diabetic patients improved following institution of intensive hemodialysis. For the few unresponsive and critical cases, 8.5% of diabetic and 7.3% of non-diabetic patients received pericardiocentesis, whereas 6.4% of diabetic and 9.8% of non-diabetic patients received surgical drainage. In terms of outcome, 85.1, 4.3 and 10.6% of diabetic patients were alive without recurrence, alive with recurrence and deceased, respectively. There was no significant difference with their non-diabetic counterparts, for which the percentages were 87.8, 4.9 and 7.3%, respectively (p > 0.05). Kaplan-Meier analysis did not find any significant difference in survival as well (p > 0.05).
  
  
  CONCLUSIONS
  Whether used in diabetics or not, intensive hemodialysis remains the primary and most effective dialysis pericarditis treatment, whereas pericardiocentesis or surgical drainage should be reserved for the few unresponsive and critical cases.
authors.affiliation: Department of Nephrology, Chang Gung Memorial Hospital, Taipei, Taiwan.
authors.forename: Jing-Ren
authors.initials: JR
authors.lastname: Tseng
authors.forename: Ming-Jse
authors.initials: MJ
authors.lastname: Lee
authors.forename: Kung-Chi
authors.initials: KC
authors.lastname: Yen
authors.forename: Cheng-Hao
authors.initials: CH
authors.lastname: Weng
authors.forename: Chih-Chia
authors.initials: CC
authors.lastname: Liang
authors.forename: I-Kuan
authors.initials: IK
authors.lastname: Wang
authors.forename: Chiz-Tzung
authors.initials: CT
authors.lastname: Chang
authors.forename: Dan-Tzu
authors.initials: DT
authors.lastname: Lin-Tan
authors.forename: Ja-Liang
authors.initials: JL
authors.lastname: Lin
authors.forename: Tzung-Hai
authors.initials: TH
authors.lastname: Yen
mesh_terms: D000368:Aged; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010493:Pericarditis / Q000209:etiology*; D012008:Recurrence; D006435:Renal Dialysis / Q000009:adverse effects*; D015996:Survival Rate; D016896:Treatment Outcome